Invention Grant
- Patent Title: Method of treating cancer by administering an anti-LGR5 monoclonal antibody
-
Application No.: US16086537Application Date: 2017-03-21
-
Publication No.: US10745487B2Publication Date: 2020-08-18
- Inventor: Christopher L. Reyes , Peter Chu , Elizabeth Doolin , Jose Iglesias
- Applicant: Bionomics Limited
- Applicant Address: AT Thebarton
- Assignee: BIONOMICS LIMITED
- Current Assignee: BIONOMICS LIMITED
- Current Assignee Address: AT Thebarton
- Agency: Knobbe, Martens, Olson & Bear LLP
- International Application: PCT/AU2017/050250 WO 20170321
- International Announcement: WO2017/161414 WO 20170928
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K39/00 ; C07K16/30 ; A61K31/513 ; A61K31/337 ; A61K31/4745 ; A61K31/519 ; A61K31/7068 ; C07K16/28 ; A61P35/00
Abstract:
The present invention relates generally to the field of cancer biology. Some embodiments of the methods and compositions provided herein relate to administration of humanized antibodies or antigen-binding fragments thereof that specifically bind to LRG5 to treat certain cancers.
Public/Granted literature
- US20190100600A1 ADMINISTRATION OF AN ANTI-LGR5 MONOCLONAL ANTIBODY Public/Granted day:2019-04-04
Information query
